Downstream Processing Featured Articles

31. Samsung Bioepis And MSD Enter Biosimilars Development And Commercialization Agreement 2/20/2013

    Samsung Bioepis Co., Ltd. and MSD, known as Merck in the United States and Canada, announced
    today they have entered into an agreement to develop and commercialize multiple pre-
    specified and undisclosed biosimilar candidates.

32. Engineered Tissue Vary Depending On Where It's Grown 8/16/2012

    MIT researchers led by Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology, have now shown that implanted cells’ therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. 

33. Novartis To Start Construction Of New Biotechnology Facility In Singapore With An Investment Of Over USD 500 Million 10/31/2012

    ​Novartis announced recently the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture technology.

34. NIH Researchers Implicate Unique Cell Type In Multiple Sclerosis 8/1/2012

    Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). 

35. COVID-19 Consortium: Competitive Collab On A Plasma-Derived Therapy 12/14/2020

    A host of global biopharma competitors are collaborating under the CoVIg-19 Plasma Alliance to secure enough convalescent plasma to produce an effective COVID-19 therapeutic at global scale. Takeda’s Dr. Thomas R. Kreil will present at the upcoming FDA/Xavier PharmaLink Conference.

36. BioPharma Industry Getting Comfortable With Complex Single-Use Devices 2/10/2012

    The rate of usage of disposables in biopharmaceutical manufacturing has increased substantially over the past six years in a variety of areas, but most notably for complex devices, that are also among the most expensive. By Eric Langer

37. High-Flow Sterile Connectors For Single-Use Applications

    Over the past decade, two developments have increased demand for high fl ow-rate connectors: Size advances in single-use bioreactors up to 2000L and the  implementation of single-use downstream.

38. Shimadzu's Nexera MP UHPLC With Multi-Plate Autosampler Provides High-Speed Analysis With Three Times More Sample Capacity For LC/MS 3/21/2012
    Shimadzu Scientific Instruments now offers the Nexera MP ultra-high performance liquid chromatography system with the SIL-30ACMP Autosampler.
39. New Cell Type Developed For Possible Treatment Of Alzheimer's And Other Brain Diseases 11/7/2012

    UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer’s.

40. Diabetes Research Reveals Important Link To Overcoming 'Lazy Insulin Granules' 7/26/2012

    Scientists at Toronto Western Research Institute have made an important discovery on the role of a SNARE protein known as VAMP8 in the release  of insulin from the pancreatic islet beta cells.